(Q43000576)
Statements
Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens (English)
Vidalin O
Fournillier A
Renard N
Chen M
Depla E
Boucreux D
Baumert T
Nakano I
Fukuda Y
Trépo C
1 reference